Company / Interest Expense
Bausch & Lomb Corp Interest Expense History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense
$421.0M
FY2025
5-year range
$0 / $421.0M
FY2021-FY2025
Trend
+5.5%
vs FY2024
Sector context
#8 of 40
Health Care
What the data says
Bausch & Lomb Corp's interest expense of $421M is higher than 80% of companies in the Health Care sector (FY2025). Interest Expense has increased for 4 consecutive years, from $0 in FY2021 to $421M in FY2025.
Based on SEC 10-K filings.
$421M in FY2025 with a 3-year CAGR of +42.3%. Top quartile in the Health Care sector.
Increased from $283M to $421M over the past 2 years.
Health Care sector context is included.
Interest Expense over time
Growth rates
- 3-Year CAGR
- +42.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 40This company $421.0M Sector average $332.7M
▼
+26.5% above sector average
Key checks
Key Insights
- Bausch & Lomb Corp's interest expense has grown for 3 consecutive years.
- 3-year CAGR of +42.3%, indicating consistent growth.
- In FY2025, interest expense increased 5.5% year-over-year.
- Ranks #8 out of 40 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $421.0M | +5.5% |
| FY2024 | $399.0M | +41.0% |
| FY2023 | $283.0M | +93.8% |
| FY2022 | $146.0M | - |
| FY2021 | $0 | - |
| FY2020 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026